Month: February 2024

1547 posts
BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062

BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062

WUXI, China, Feb. 25, 2024 /PRNewswire/ — BioCity Biopharma is pleased to announce…
Paris Rhône Elevates Parenting Experience with the 2K HD Video Baby Monitor – Redefining Peace of Mind for Modern Parents

Paris Rhône Elevates Parenting Experience with the 2K HD Video Baby Monitor – Redefining Peace of Mind for Modern Parents

SHENZHEN, China, Feb. 26, 2024 /PRNewswire/ — Parenting is a beautiful journey…
Antelope Enterprise Announces Closing of .3 Million Registered Direct Offering and Private Placement

Antelope Enterprise Announces Closing of $1.3 Million Registered Direct Offering and Private Placement

CHENGDU, China, Feb. 26, 2024 /PRNewswire/ — Antelope Enterprise Holdings Limited (NASDAQ…
Huawei Advances Intelligence as Operators Embrace First Year of Commercial 5.5G

Huawei Advances Intelligence as Operators Embrace First Year of Commercial 5.5G

BARCELONA, Spain, Feb. 26, 2024 /PRNewswire/ — During MWC Barcelona 2024, Huawei hosted…
Australia-Mainland China Relations Warm Up, But Risks Remain

Australia-Mainland China Relations Warm Up, But Risks Remain

Key View  Australia-Mainland China relations have improved as both nations rekindle their…
CN Energy Group Provides Preliminary Unaudited Financial Information for the First Three Months of Fiscal Year 2024 and Announces an Operations Update

CN Energy Group Provides Preliminary Unaudited Financial Information for the First Three Months of Fiscal Year 2024 and Announces an Operations Update

Preliminary revenue for the first three months of fiscal year 2024 is…
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved…
GSMA MWC BARCELONA BRINGS INDUSTRIES TOGETHER FOR FOUR DAYS OF DISCUSSION AND DEBATE ON THE FUTURE OF CONNECTIVITY

GSMA MWC BARCELONA BRINGS INDUSTRIES TOGETHER FOR FOUR DAYS OF DISCUSSION AND DEBATE ON THE FUTURE OF CONNECTIVITY

MWC Barcelona 2024 welcomes the most iconic names in connectivity for nine…